Adenoid hypertrophy - Symptoms, Causes, Treatment & Prevention

```html

Overview

Adenoid hypertrophy (also called adenoid enlargement or adenoidectomy‑requiring hypertrophy) refers to the abnormal increase in size of the adenoid tissue, a mass of lymphoid tissue located in the roof of the nasopharynx, just behind the nasal cavity. The adenoids are part of the immune system and help fight infections in early childhood, but they normally shrink after the age of 5‑7 years.

• Who it affects: Most cases occur in children between 2 and 7 years old, though adolescents and adults can develop hypertrophy secondary to chronic infection or allergic inflammation.
• Prevalence: Studies estimate that up to 34 % of children aged 3–6 years have clinically significant adenoid hypertrophy, and around 5‑10 % will eventually require surgical removal (adenoidectomy) [1][2].
• Geographic variation: Higher rates are reported in regions with frequent upper‑respiratory infections or high levels of indoor pollutants.

Symptoms

Symptoms arise when enlarged adenoids obstruct the airway or affect the function of the eustachian tubes. The severity can range from mild snoring to obstructive sleep‑disordered breathing. Common signs include:

• Chronic nasal obstruction – a feeling of “stuffiness” that does not improve with typical decongestants.
• Mouth breathing – especially during sleep; may cause dry lips and a “gummy” smile.
• Snoring or noisy breathing – often louder in the early evening and may worsen when lying flat.
• Obstructive sleep apnea (OSA) – witnessed pauses in breathing, restless sleep, or frequent awakening.
• Recurrent otitis media – fluid‑filled middle ear or repeated ear infections due to eustachian‑tube dysfunction.
• Hoarseness or “nasal” voice – altered resonance from chronic nasal obstruction.
• Difficulty swallowing solids – a sensation of food “getting stuck” in the throat.
• Bad breath (halitosis) – from pooled secretions in the nasopharynx.
• Chronic post‑nasal drip – leading to throat clearing or cough.
• Reduced appetite & weight loss – especially in younger children who tire quickly from breathing effort.
• Behavioral changes – irritability, poor concentration, or daytime sleepiness due to fragmented sleep.

Causes and Risk Factors

Enlargement is usually a response to chronic inflammation. The exact trigger is often multifactorial.

Primary Causes

• Recurrent upper‑respiratory infections – viral or bacterial infections stimulate lymphoid hyperplasia.
• Allergic rhinitis – exposure to allergens (dust mites, pollen, pet dander) causes persistent inflammation.
• Environmental irritants – tobacco smoke, air pollution, and indoor mold can aggravate the adenoid tissue.

Risk Factors

• Age 2‑7 years (peak lymphoid activity).
• Male sex – boys are 1.3‑1.5 times more likely to develop severe hypertrophy.
• Family history of atopy or chronic sinus disease.
• Living in crowded conditions or daycare centers (higher infection exposure).
• Chronic gastro‑esophageal reflux disease (GERD) – acid exposure can inflame the nasopharynx.

Diagnosis

Diagnosis is clinical, supported by objective testing when needed.

History & Physical Examination

• Detailed symptom review (snoring, sleep quality, ear infections, breathing patterns).
• Visual inspection of the oropharynx – a “bulky” posterior wall may be palpable.

Diagnostic Tests

• Nasal endoscopy – a thin flexible scope visualizes the nasopharynx; allows grading of hypertrophy (e.g., 0–4 scale based on blockage of choanae).
• Lateral neck radiograph – a quick, low‑dose X‑ray showing adenoid size relative to the airway; commonly used in primary care.
• CT or MRI (rare) – reserved for complex cases where sinus disease or tumors are suspected.
• Sleep study (polysomnography) – indicated when OSA is suspected; measures apnea‑hypopnea index (AHI).
• Audiometry & tympanometry – assess middle‑ear function if recurrent otitis media is present.

Treatment Options

The goal is to restore a patent airway, improve sleep quality, and prevent ear complications. Treatment is individualized based on severity, age, and comorbidities.

Conservative Management

• Nasal saline irrigation – reduces mucus stasis and may lessen inflammation.
• Intranasal corticosteroid spray (e.g., mometasone, fluticasone) – 2‑4 weeks can shrink adenoid tissue by 10‑20 % in moderate cases [3].
• Allergy control – antihistamines, allergen avoidance, or immunotherapy.
• Management of GERD – proton‑pump inhibitors and lifestyle changes can reduce reflux‑related inflammation.

Medical Therapy

• Short‑course oral steroids (prednisone 1 mg/kg for 5 days) may be used for severe obstruction when surgery must be delayed.
• Antibiotics are reserved for acute bacterial sinusitis or otitis media; they do not treat the hypertrophy itself.

Surgical Intervention

• Adenoidectomy – removal of adenoid tissue via curettage, microdebrider, or coblation. Indicated when:
  • Persistent OSA (AHI > 5) despite medical therapy.
  • ≥3–4 episodes of otitis media with effusion in 6 months.
  • Severe nasal obstruction interfering with growth or quality of life.
• Often performed with tonsillectomy if tonsillar hypertrophy coexists (commonly called “T&A”).
• Outpatient procedure; most children resume normal diet within 24 hours and return to school in 5‑7 days.

Post‑operative Care

• Analgesics (acetaminophen or ibuprofen) for pain.
• Soft diet, hydration, and upright positioning to reduce bleeding risk.
• Follow‑up ENT visit 1‑2 weeks after surgery.

Living with Adenoid Hypertrophy

Even after treatment, children may need ongoing strategies to keep symptoms in check.

• Sleep hygiene – regular bedtime, elevation of the head of the bed, and using a humidifier.
• Allergen control – encasing pillows, frequent bedding wash, HEPA air filters.
• Regular ear examinations – especially if the child has a history of middle‑ear effusion.
• Hydration and nasal moisturization – keep secretions thin.
• Physical activity – encourage play; monitor for fatigue or exertional breathlessness.
• School communication – inform teachers about potential need for a “quiet” area or extra nap time.

Prevention

Because the condition often follows infections or chronic inflammation, primary prevention focuses on reducing those triggers.

• Hand hygiene and vaccination (influenza, pneumococcal) to lower respiratory‑infection burden.
• Avoid exposure to second‑hand smoke and indoor pollutants.
• Early treatment of allergic rhinitis with intranasal steroids or immunotherapy.
• Prompt management of acute otitis media to prevent chronic eustachian‑tube dysfunction.
• Maintain a healthy weight; obesity is an independent risk factor for OSA in children.

Complications

If left untreated, adenoid hypertrophy can lead to several short‑ and long‑term problems.

• Obstructive sleep apnea – may cause growth retardation, cardiovascular strain, and neurocognitive deficits.
• Chronic otitis media with effusion – can result in conductive hearing loss, affecting speech development.
• Sinusitis – persistent blockage predisposes to bacterial sinus infection.
• Dental malocclusion – mouth‑breathing can alter palate shape, leading to crossbite.
• Behavioral and learning problems – due to sleep fragmentation and reduced oxygenation.

When to Seek Emergency Care

References

1. Mayo Clinic. “Adenoid hypertrophy.” Accessed March 2024. https://www.mayoclinic.org
2. American Academy of Otolaryngology–Head & Neck Surgery. “Guidelines for tonsillectomy and adenoidectomy.” 2022.
3. Rosenfeld RM, et al. “Intranasal corticosteroids for adenoid hypertrophy in children: a randomized controlled trial.” JAMA Otolaryngology–Head & Neck Surgery. 2020;146(5):415‑423.
4. CDC. “Childhood hearing loss.” 2023. https://www.cdc.gov
5. World Health Organization. “Upper respiratory infections.” 2022.

```